Free Trial

16,000 Shares in Stericycle, Inc. (NASDAQ:SRCL) Acquired by Cannon Global Investment Management LLC

Stericycle logo with Business Services background

Cannon Global Investment Management LLC acquired a new stake in Stericycle, Inc. (NASDAQ:SRCL - Free Report) in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 16,000 shares of the business services provider's stock, valued at approximately $976,000. Stericycle makes up approximately 1.6% of Cannon Global Investment Management LLC's portfolio, making the stock its 14th biggest position.

Other hedge funds also recently made changes to their positions in the company. First Eagle Investment Management LLC boosted its holdings in Stericycle by 5.2% in the first quarter. First Eagle Investment Management LLC now owns 242,975 shares of the business services provider's stock valued at $12,817,000 after purchasing an additional 12,000 shares during the last quarter. Illinois Municipal Retirement Fund acquired a new stake in shares of Stericycle during the first quarter worth approximately $756,000. Sei Investments Co. increased its stake in shares of Stericycle by 5.9% in the first quarter. Sei Investments Co. now owns 1,124,481 shares of the business services provider's stock worth $59,316,000 after buying an additional 63,112 shares during the last quarter. Quantbot Technologies LP bought a new stake in shares of Stericycle in the first quarter worth $1,023,000. Finally, BNP Paribas Financial Markets raised its holdings in Stericycle by 21.5% in the first quarter. BNP Paribas Financial Markets now owns 7,957 shares of the business services provider's stock valued at $420,000 after acquiring an additional 1,408 shares in the last quarter. Hedge funds and other institutional investors own 98.82% of the company's stock.

Stericycle Stock Performance

Stericycle stock traded up $0.51 during mid-day trading on Friday, reaching $61.98. The company's stock had a trading volume of 5,241,236 shares, compared to its average volume of 813,216. The firm has a market cap of $5.75 billion, a price-to-earnings ratio of 163.11, a PEG ratio of 3.36 and a beta of 1.10. Stericycle, Inc. has a twelve month low of $37.78 and a twelve month high of $61.99. The business has a 50 day moving average price of $60.82 and a 200-day moving average price of $56.76. The company has a current ratio of 1.13, a quick ratio of 1.13 and a debt-to-equity ratio of 0.55.

Wall Street Analyst Weigh In

Separately, StockNews.com assumed coverage on shares of Stericycle in a report on Sunday, October 27th. They set a "hold" rating for the company. One research analyst has rated the stock with a sell rating, four have issued a hold rating and two have given a buy rating to the company. According to MarketBeat, the stock currently has a consensus rating of "Hold" and an average price target of $74.00.

Check Out Our Latest Stock Analysis on Stericycle

Stericycle Profile

(Free Report)

Stericycle, Inc, together with its subsidiaries, provides regulated waste and compliance services in the United States, Europe, and internationally. The company offers regulated waste and compliance services, including regulated medical waste, sharps waste management and disposal, pharmaceutical waste management and disposal, chemotherapy waste and disposal, controlled substance waste disposal, healthcare hazardous waste, and integrated waste stream solutions; specialty services, such as MedDrop medication collection kiosks, safe community solutions, SafeDrop sharps mailback solutions, and airport and maritime waste services; medical supply store services, that includes sharps and disposable biohazardous waste containers, infection control supplies, and seal&send medication mail back; and compliance solutions including Steri-Safe compliance solutions.

See Also

Institutional Ownership by Quarter for Stericycle (NASDAQ:SRCL)

Should you invest $1,000 in Stericycle right now?

Before you consider Stericycle, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Stericycle wasn't on the list.

While Stericycle currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

2025 Gold Forecast: A Perfect Storm for Demand Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Why Whitestone REIT is Outperforming in 2024: 35% Growth & Monthly Dividends
Why SoundHound Stock Dip Could Mean Big Gains for 2025 Investors
Nintendo Stock: Buy Before the 2025 Switch Platform Hits!

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines